Gilead Sciences Wins Approval For Highly Effective HIV Prevention Drug

investors.com/news/technology/gilead-sciences-gilead-stock-lenacapavir-hiv-prevention

Gilead Sciences won Food and Drug Administration approval Wednesday for a highly effective drug to prevent HIV infection.
The post Gilead Sciences Wins Approval For Highly Effective HIV Prevention Drug appeared first on Investor's Business Daily.

This story appeared on investors.com, 2025-06-18 18:53:14.
The Entire Business World on a Single Page. Free to Use →